Article Sidebar
Published:
Aug 19, 2023DOI:
10.4314/tjpr.v22i7.2Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
KLF11 enhances the effect of liraglutide in high glucoseinduced Schwann cells by regulating endoplasmic reticulum stress and autophagy through inactivation of P38 MAPK
Abstract
Purpose: To investigate the effect of Kruppel-Like Factor 11 (KLF11) on diabetic peripheral neuropathy (DPN).
Methods: Schwann cells, RSC96, were treated with high glucose to induce DPN. Cell viability and apoptosis were evaluated by flow cytometry. Expressions of KLF11 and proteins involved in endoplasmic reticulum (ER) stress and autophagy were evaluated by western blot.
Results: The KLF11 was downregulated in high glucose-induced RSC96. Cell viability of RSC96 was decreased and apoptosis increased by high glucose. Overexpression of KLF11 restored viability and decreased apoptosis of high glucose-induced RSC96. High glucose-induced an increase in proteins involved in ER stress in RSC96, and but reversed by KLF11 overexpression. Overexpression of KLF11 also attenuated high glucose-induced decrease in LC3 and Beclin1 expression in RSC96 cells. Phosphorylated p38 (p-p38) in high glucose-induced RSC96 decreased upon overexpression of KLF11. Liraglutide treatment increased cell viability and autophagy, decreased cell apoptosis, and inhibited ER stress in high glucose-induced RSC96. Furthermore, KLF11 enhanced the protective activity of liraglutide against high glucose-induced cytotoxicity in Schwann cells.
Conclusion: Overexpression of KLF11 exerts a neuroprotective effect against DPN by promotingu autophagy and inhibiting ER stress via inactivation of p38 signaling, suggesting that KLF11 might be a target for DPN.
